Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|March 31, 2012
Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasisVito Ferro, Ligong Liu, Ken D Johnstone, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapyKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Oncogene|August 7, 2023
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interactionUpasana Ray, Prabhu Thirusangu, Ling Jin, et al.
Journal for Immunotherapy of Cancer|January 12, 2023
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumorsCharlotte Lemech, Keith Dredge, Darryn Bampton, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying KineticsEdward Hammond, Vito Ferro
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesBoris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Medicine, Conflict, and Survival|June 5, 2002
Closing loopholes in the Biological Weapons ConventionJan van Aken, Edward Hammond
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|April 5, 2008
An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratoriesMargaret S Race, Edward Hammond
Molecular Carcinogenesis|July 9, 2011
Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell linesAshwani Khurana, Han W Tun, Laura Marlow, et al.
Oncotarget|September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancerSusmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
Pageof 8